Summary Since 1989, 18 second-generation antiseizure medications have reached the
market, resulting in a greatly increased range of treatment options for patients and …

Over the last decade, advances in genetics, neuroimaging and EEG have enabled the
aetiology of epilepsy to be identified earlier in the disease course than ever before. At the …

Objective To consolidate current understanding of detection sensitivity of brain 18 F-FDG
PET scans in the diagnosis of autoimmune encephalitis and to define specific metabolic …

Abstract Purpose of Review To provide an overview and highlight recent updates in the field
of paraneoplastic neurologic disorders. Recent Findings The prevalence of paraneoplastic …

Correctly diagnosing and classifying seizures and epilepsies is paramount to ensure the
delivery of optimal care to patients with epilepsy. Focal seizures, defined as those that …

We provide an overview of the varied presentations of paraneoplastic neurological
syndromes. We also review the onconeural antibodies and their particular oncological and …

Automatic seizure detection technology is of great significance to reduce workloads of
neurologists for epilepsy diagnosis and treatments. Imbalanced classification is a challenge …

New-onset refractory status epilepticus (NORSE) is “a clinical presentation, not a specific
diagnosis, in a patient without active epilepsy or other preexisting relevant neurological …

Phagocytes maintain homeostasis in a healthy brain. Upon injury, they are essential for
repairing damaged tissue, recruiting other immune cells, and releasing cytokines as the first …

Epilepsy is a common chronic neurological disorder in modern society. One of the major
unmet challenges is that current antiseizure medications are basically not disease …